Akebia Therapeutics reported $2K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 71K 0
Akebia Therapeutics AKBA:US USD 2K 0
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Amgen AMGN:US USD 32.37B 1.03B
Ardelyx ARDX:US USD 19K 4K
Astellas Pharma 4503:JP JPY 103B 0
AstraZeneca AZN:LN USD 387M 0
Avrobio Inc AVRO:US USD 4K 0
Bayer BAYN:GR EUR 2.52B 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Exelixis EXEL:US USD 323K 1000
GlaxoSmithKline GSK:LN GBP 1.35B 0
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Ironwood Pharmaceuticals IRWD:US USD 153K 0
Karyopharm Therapeutics KPTI:US USD 8K 0
Lexicon Pharmaceuticals LXRX:US USD 189K 39K
Moderna Inc MRNA:US USD 38.7K 500
Nektar Therapeutics NKTR:US USD 19K 0
Opko Health OPK:US USD 7.81M 8K
Ptc Therapeutics PTCT:US USD 71K 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Roche Holding ROG:VX 107M 53M
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 185K 1000
Vanda Pharmaceuticals VNDA:US USD 57K 0